Skip to main content
Top
Published in: Journal of Gastroenterology 6/2012

01-06-2012 | Original Article—Alimentary Tract

Analysis of colorectal cancer morphology in relation to sex, age, location, and family history

Authors: Sam Ghazi, Ulrik Lindforss, Greger Lindberg, Elisabeth Berg, Annika Lindblom, Nikos Papadogiannakis, The Low-Risk Colorectal Cancer Study Group

Published in: Journal of Gastroenterology | Issue 6/2012

Login to get access

Abstract

Background

Studies of colorectal cancer (CRC) have suggested different mechanisms of carcinogenesis in men and women, young and old patients, right- and left sided tumors, and sporadic and familial tumors. These differences might be reflected in morphology.

Methods

CRCs from 1613 patients operated on in 2004–2006 in Sweden were histologically reviewed. Morphology was examined in relation to sex, age groups, location, and family history.

Results

Tumors in the right colon were larger, of higher stage, more often poorly differentiated, more mucin-producing, more often had a peritumoral lymphocytic infiltrate and a high level of tumor-infiltrating lymphocytes (TILs), and more seldom had an infiltrating margin than tumors in the left colon and rectum (p < 0.0001 for most features). Young patients (<60 years) more seldom had multiple tumors but more often had perineural invasion, an infiltrative tumor margin, and high-stage tumors. Three features, TILs, medullary tumors, and invasive tumor margin, were related to sex. Only vascular invasion was related to familiality.

Conclusion

Location is the factor that has the most influence on tumor morphology. The results support the idea that different carcinogenic mechanisms may be involved in the right and left colon. Age is the most important determinant for the presence of multiple tumors and is a crucial factor for the aggressiveness of the disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference George B, Kopetz S. Predictive and prognostic markers in colorectal cancer. Curr Oncol Rep. 2011 [Epub ahead of print]. George B, Kopetz S. Predictive and prognostic markers in colorectal cancer. Curr Oncol Rep. 2011 [Epub ahead of print].
2.
go back to reference Woods SE, Narayanan K, Engel A. The influence of gender on colon cancer stage. J Womens Health. 2005;14:502–6.CrossRef Woods SE, Narayanan K, Engel A. The influence of gender on colon cancer stage. J Womens Health. 2005;14:502–6.CrossRef
3.
go back to reference Koo JH, Jalaludin B, Wong SK, Kneebone A, Connor SJ, Leong RW. Improved survival in young women with colorectal cancer. Am J Gastroenterol. 2008;6:1488–95.CrossRef Koo JH, Jalaludin B, Wong SK, Kneebone A, Connor SJ, Leong RW. Improved survival in young women with colorectal cancer. Am J Gastroenterol. 2008;6:1488–95.CrossRef
4.
go back to reference Woods SE, Basho S, Engel AJ. The influence of gender on colorectal cancer stage: the state of Ohio, 1996–2001. J Womens Health. 2006;15:877–81.CrossRef Woods SE, Basho S, Engel AJ. The influence of gender on colorectal cancer stage: the state of Ohio, 1996–2001. J Womens Health. 2006;15:877–81.CrossRef
5.
go back to reference Fairley TL, Cardinez CJ, Martin J, Alley L, Friedman C, Edwards B, et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998–2001. Cancer. 2006;107:1153–61.PubMedCrossRef Fairley TL, Cardinez CJ, Martin J, Alley L, Friedman C, Edwards B, et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998–2001. Cancer. 2006;107:1153–61.PubMedCrossRef
6.
go back to reference Heys SD, Sherif A, Bagley JS, Brittenden J, Smart C, Eremin O. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg. 1994;81:685–8.PubMedCrossRef Heys SD, Sherif A, Bagley JS, Brittenden J, Smart C, Eremin O. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg. 1994;81:685–8.PubMedCrossRef
7.
go back to reference Snaebjornsson P, Jonasson L, Jonsson T, Möller PH, Theodors A, Jonasson JG. Colon cancer in Iceland—a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients’ age. Int J Cancer. 2010;127:2645–53.PubMedCrossRef Snaebjornsson P, Jonasson L, Jonsson T, Möller PH, Theodors A, Jonasson JG. Colon cancer in Iceland—a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients’ age. Int J Cancer. 2010;127:2645–53.PubMedCrossRef
8.
go back to reference Nawa T, Kato J, Kawamoto H, Okada H, Yamamoto H, Kohno H, et al. Difference in right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol. 2008;23:418–23.PubMedCrossRef Nawa T, Kato J, Kawamoto H, Okada H, Yamamoto H, Kohno H, et al. Difference in right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol. 2008;23:418–23.PubMedCrossRef
9.
go back to reference Meguid RA, Slidell MB, Wolfgang CL, Wolfgang CL, Chang DC, Ahuja N. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol. 2008;15:2388–94.PubMedCrossRef Meguid RA, Slidell MB, Wolfgang CL, Wolfgang CL, Chang DC, Ahuja N. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol. 2008;15:2388–94.PubMedCrossRef
10.
go back to reference Levi F, Randimbison L, La Vecchia C. Trends in subsite distribution of colorectal cancers and polyps from the Vaud Cancer Registry. Cancer. 1993;72:46–50.PubMedCrossRef Levi F, Randimbison L, La Vecchia C. Trends in subsite distribution of colorectal cancers and polyps from the Vaud Cancer Registry. Cancer. 1993;72:46–50.PubMedCrossRef
11.
go back to reference Obrand DI, Gordon PH. Continued change in the distribution of colorectal carcinoma. Br J Surg. 1998;85:246–8.PubMedCrossRef Obrand DI, Gordon PH. Continued change in the distribution of colorectal carcinoma. Br J Surg. 1998;85:246–8.PubMedCrossRef
12.
go back to reference Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology. 2003;124:1574–94.PubMedCrossRef Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology. 2003;124:1574–94.PubMedCrossRef
13.
go back to reference Lindblom A, Ghazi S, Liu T, Lagerstedt K, Papadogiannakis N. Hereditary non-polyposis colorectal cancer (HNPCC); definition and diagnostics in 2005. Research Trends. 2006;2:21–31. Lindblom A, Ghazi S, Liu T, Lagerstedt K, Papadogiannakis N. Hereditary non-polyposis colorectal cancer (HNPCC); definition and diagnostics in 2005. Research Trends. 2006;2:21–31.
14.
go back to reference Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res. 1998;4:1–6.PubMed Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res. 1998;4:1–6.PubMed
15.
go back to reference Ward R, Meagher A, Tomlinson I, O’Connor T, Norrie M, Wu R, et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut. 2001;48:821–9.PubMedCrossRef Ward R, Meagher A, Tomlinson I, O’Connor T, Norrie M, Wu R, et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut. 2001;48:821–9.PubMedCrossRef
16.
go back to reference Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424–5.PubMedCrossRef Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424–5.PubMedCrossRef
17.
go back to reference Ghazi S, von Holst S, Picelli S, Lindforss U, Tenesa A, Farrington SM, et al. Colorectal cancer susceptibility loci in a population-based study: associations with morphological parameters. Am J Pathol. 2010;177:2688–93.PubMedCrossRef Ghazi S, von Holst S, Picelli S, Lindforss U, Tenesa A, Farrington SM, et al. Colorectal cancer susceptibility loci in a population-based study: associations with morphological parameters. Am J Pathol. 2010;177:2688–93.PubMedCrossRef
18.
go back to reference Wittekind C, Greene FL, Hutter RV, Sobin LH, Klimpfinger M. TNM atlas. 5th ed. Paris: Springer; 2005.CrossRef Wittekind C, Greene FL, Hutter RV, Sobin LH, Klimpfinger M. TNM atlas. 5th ed. Paris: Springer; 2005.CrossRef
19.
go back to reference Hamilton SR, Aaltonen LA. World Health Organization classification of tumors, pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2000. Hamilton SR, Aaltonen LA. World Health Organization classification of tumors, pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2000.
20.
go back to reference Chandler I, Houlston RS. Interobserver agreement in grading colorectal cancers–findings from a nationwide web-based survey of histopathologists. Histopathology. 2008;52:494–9.PubMedCrossRef Chandler I, Houlston RS. Interobserver agreement in grading colorectal cancers–findings from a nationwide web-based survey of histopathologists. Histopathology. 2008;52:494–9.PubMedCrossRef
21.
go back to reference Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001;159:2107–16.PubMedCrossRef Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001;159:2107–16.PubMedCrossRef
22.
go back to reference Smyrk TC, Watson P, Kaul K, Lynch HT. Tumor infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91:2417–22.PubMedCrossRef Smyrk TC, Watson P, Kaul K, Lynch HT. Tumor infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91:2417–22.PubMedCrossRef
23.
go back to reference Jass JR. Role of the pathologist in the diagnosis of hereditary non-polyposis colorectal cancer. Dis Marker. 2004;20:215–24. Jass JR. Role of the pathologist in the diagnosis of hereditary non-polyposis colorectal cancer. Dis Marker. 2004;20:215–24.
24.
go back to reference Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumor “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;40:127–32.PubMedCrossRef Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumor “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;40:127–32.PubMedCrossRef
25.
go back to reference Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology. 1996;28:543–8.PubMedCrossRef Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology. 1996;28:543–8.PubMedCrossRef
26.
go back to reference Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, Leppert M, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev. 2001;9:917–23. Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, Leppert M, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev. 2001;9:917–23.
27.
go back to reference Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol. 2005;207:53–60.PubMedCrossRef Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol. 2005;207:53–60.PubMedCrossRef
28.
go back to reference Breivik J, Lothe RA, Meling GI, Meling GI, Rognum TO, Børresen-Dale AL, et al. Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer. 1997;74:664–9.PubMedCrossRef Breivik J, Lothe RA, Meling GI, Meling GI, Rognum TO, Børresen-Dale AL, et al. Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer. 1997;74:664–9.PubMedCrossRef
29.
go back to reference Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, et al. Estrogen reduces and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res. 2001;61:126–30.PubMed Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, et al. Estrogen reduces and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res. 2001;61:126–30.PubMed
30.
go back to reference Börger ME, Gosens MJEM, Jeuken JWM, van Kempen LC, van de Velde CJ, van Krieken JH, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol. 2007;212:278–86.PubMedCrossRef Börger ME, Gosens MJEM, Jeuken JWM, van Kempen LC, van de Velde CJ, van Krieken JH, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol. 2007;212:278–86.PubMedCrossRef
31.
go back to reference Gopalan V, Smith RA, Ho YH, Lam AK. Signet-ring cell carcinoma of colorectum–current perspectives and molecular biology. Int J Colorectal Dis. 2011;26:127–33.PubMedCrossRef Gopalan V, Smith RA, Ho YH, Lam AK. Signet-ring cell carcinoma of colorectum–current perspectives and molecular biology. Int J Colorectal Dis. 2011;26:127–33.PubMedCrossRef
32.
33.
go back to reference Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol. 2003;16:376–88.PubMedCrossRef Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol. 2003;16:376–88.PubMedCrossRef
34.
go back to reference Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum. 1991;34:798–804.PubMedCrossRef Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum. 1991;34:798–804.PubMedCrossRef
35.
go back to reference Lee YT. Local and regional recurrence of carcinoma of the colon and rectum: tumour-host factors and adjuvant therapy. Surg Oncol. 1995;4:283–93.PubMedCrossRef Lee YT. Local and regional recurrence of carcinoma of the colon and rectum: tumour-host factors and adjuvant therapy. Surg Oncol. 1995;4:283–93.PubMedCrossRef
36.
go back to reference Harrison JC, Dean PJ, el-Zeky F, Vander Zwaag R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol. 1994;25:498–505.PubMedCrossRef Harrison JC, Dean PJ, el-Zeky F, Vander Zwaag R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol. 1994;25:498–505.PubMedCrossRef
37.
go back to reference Heys SD, O’Hanrahan TJ, Brittenden J, Eremin O. Colorectal cancers in young patients: a review of the literature. Eur J Surg Oncol. 1994;3:225–31. Heys SD, O’Hanrahan TJ, Brittenden J, Eremin O. Colorectal cancers in young patients: a review of the literature. Eur J Surg Oncol. 1994;3:225–31.
38.
go back to reference Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer. 1994;73:2076–82.PubMedCrossRef Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer. 1994;73:2076–82.PubMedCrossRef
39.
go back to reference Michelassi F, Ayala JJ, Balestracci T, Goldberg R, Chappell R, Block GE. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma. Ann Surg. 1991;214:11–8.PubMed Michelassi F, Ayala JJ, Balestracci T, Goldberg R, Chappell R, Block GE. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma. Ann Surg. 1991;214:11–8.PubMed
40.
go back to reference Takebayashi Y, Akiyama SI, Yamada K, Akiba S, Aikou T. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer. 1996;78:226–31.PubMedCrossRef Takebayashi Y, Akiyama SI, Yamada K, Akiba S, Aikou T. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer. 1996;78:226–31.PubMedCrossRef
41.
go back to reference Compton CC, Fielding L, Burgart LJ. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 1999;124:979–94. Compton CC, Fielding L, Burgart LJ. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 1999;124:979–94.
42.
go back to reference Sternberg A, Amar A, Alfici R, Groisman G. Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma. J Clin Pathol. 2002;55:17–21.PubMedCrossRef Sternberg A, Amar A, Alfici R, Groisman G. Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma. J Clin Pathol. 2002;55:17–21.PubMedCrossRef
43.
go back to reference Blenkinsopp WK, Stewart-Brown S, Blesovsky L, Kearney G, Fielding LP. Histopathology reporting in large bowel cancer. J Clin Pathol. 1981;34:509–13.PubMedCrossRef Blenkinsopp WK, Stewart-Brown S, Blesovsky L, Kearney G, Fielding LP. Histopathology reporting in large bowel cancer. J Clin Pathol. 1981;34:509–13.PubMedCrossRef
44.
go back to reference Zlobec I, Höller S, Tornillo L, Terracciano L, Lugli A. Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer. Dis Colon Rectum. 2009;52:1114–21.PubMedCrossRef Zlobec I, Höller S, Tornillo L, Terracciano L, Lugli A. Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer. Dis Colon Rectum. 2009;52:1114–21.PubMedCrossRef
45.
go back to reference Lin M, Lin H-Z, Ma S-P, Ji P, Xie D, Yu JX. Vascular endothelial growth factor-A and -C: expression and correlations with lymphatic metastases and prognosis in colorectal cancer. Med Oncol. 2011;28:151–8.PubMedCrossRef Lin M, Lin H-Z, Ma S-P, Ji P, Xie D, Yu JX. Vascular endothelial growth factor-A and -C: expression and correlations with lymphatic metastases and prognosis in colorectal cancer. Med Oncol. 2011;28:151–8.PubMedCrossRef
46.
go back to reference Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst. 2007;99:291–9.PubMedCrossRef Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst. 2007;99:291–9.PubMedCrossRef
47.
go back to reference Olsson L, Lindblom A. Family history of colorectal cancer in a Swedish county. Fam Cancer. 2003;2:87–93.PubMedCrossRef Olsson L, Lindblom A. Family history of colorectal cancer in a Swedish county. Fam Cancer. 2003;2:87–93.PubMedCrossRef
48.
go back to reference Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC. Histological categorization of fibrotic cancer stroma in advanced rectal cancer. Gut. 2004;53:581–6.PubMedCrossRef Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC. Histological categorization of fibrotic cancer stroma in advanced rectal cancer. Gut. 2004;53:581–6.PubMedCrossRef
Metadata
Title
Analysis of colorectal cancer morphology in relation to sex, age, location, and family history
Authors
Sam Ghazi
Ulrik Lindforss
Greger Lindberg
Elisabeth Berg
Annika Lindblom
Nikos Papadogiannakis
The Low-Risk Colorectal Cancer Study Group
Publication date
01-06-2012
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 6/2012
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-011-0520-9

Other articles of this Issue 6/2012

Journal of Gastroenterology 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine